Status:

COMPLETED

Follow-up Study After Manchester Operation for Pelvic Organ Prolapse

Lead Sponsor:

Oslo University Hospital

Conditions:

Pelvic Organ Prolapse

Eligibility:

FEMALE

18+ years

Brief Summary

Native tissue repair for pelvic organ prolapse (POP) is the predominant surgical technique in the investigators department and the Manchester operation the preferred procedure. The investigators long-...

Detailed Description

Many studies have shown high recurrence rates after POP surgical repair using native tissue techniques, and this led to the introduction of synthetic meshes in vaginal repair in the early 2000s. Howev...

Eligibility Criteria

Inclusion

  • Women aged ≥ 18 years, understanding and reading Scandinavian or English language and being able to sign an informed consent. Non- Scandinavian speakers can be enrolled in the study as long as they understand and can communicate in English or Norwegian.
  • Subjective distress from pelvic organ prolapse
  • Cystocele Stage I - III with descent of the cervix Stage I-III, with or without a defect of the posterior wall (rectocele, enterocele, hypotrophic perineum).

Exclusion

  • Previous total hysterectomy (including removal of the cervix and the cardinal ligaments) or previous subtotal hysterectomy (removal of copus uteri).
  • Previous surgery for POP
  • Patients with a true Uterine prolapse with a descent of the corpus uteri stage II-III and not just an elongated cervix, as this group may benefit from other procedures than a Manchester operation (vaginal hysterectomy and sacrospinous fixation)
  • Unable to understand patient information (in Norwegian or English) and sign an informed consent.
  • Patients in whom a colpocleisis (closing of the vagina) is deemed the better surgical treatment, such as in elderly women not sexually active and not interested in future vaginal intercourse.

Key Trial Info

Start Date :

October 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 1 2023

Estimated Enrollment :

209 Patients enrolled

Trial Details

Trial ID

NCT02246387

Start Date

October 1 2014

End Date

January 1 2023

Last Update

November 2 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Gynekologisk avdeling, Oslo Universitetssykehus Ullevål

Oslo, Norway, 0424